VEA
EVLO

Virtus ETF Advisers’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Virtus ETF Advisers’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,051
Closed -$71K – 492
2022
Q1 		$71K Sell
1,051
-62
-6% -$5.16K 0.03% 351
2021
Q4 		$135K Buy
1,113
+462
+71% +$78K 0.05% 364
2021
Q3 		$92K Sell
651
-34
-5% -$6.74K 0.04% 387
2021
Q2 		$188K Buy
+685
New +$173K 0.08% 374

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtus ETF Advisers's EVLO Position: Q2 2022 in Review

Virtus ETF Advisers sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 1,051 shares — an estimated $71K sold.

Virtus ETF Advisers first reported a position in EVLO in Q2 2021 and held it in 4 quarters. The position peaked at $188K in Q2 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • Virtus ETF Advisers reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 1,051 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $71K.
  • Virtus ETF Advisers first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Virtus ETF Advisers's Evelo Biosciences, Inc. Common Stock position peaked at $188K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Virtus ETF Advisers's 13F filing for Q2 2022, filed 12 Aug 2022.